Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: Long-term observation

Movement Disorders

Volumn 24, Issue 4, 2009, Pages 555-561

  Romito, Luigi M ^a,b   Contarino, Maria Fiorella ^c   Vanacore, Nicola ^d   Bentivoglio, Anna Rita ^c   Scerrati, Massimo ^e   Albanese, Alberto ^a,b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Deep brain stimulation; Dopamine agonists; Levodopa; Parkinson's disease; Subthalamic nucleus; Surgery

Indexed keywords

APOMORPHINE; BOTULINUM TOXIN; BROMOCRIPTINE; CLOZAPINE; LEVODOPA; PERGOLIDE; ROPINIROLE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AKINESIA; APATHY; APRAXIA; ARTICLE; BILATERAL BRAIN DEPTH STIMULATION; BODY POSTURE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DOPAMINERGIC ACTIVITY; DYSARTHRIA; DYSKINESIA; DYSTONIA; EYELID OPENING APRAXIA; FEMALE; GAIT DISORDER; HUMAN; LONG TERM CARE; MALE; MANIC PSYCHOSIS; MOTOR PERFORMANCE; MUSCLE HYPOTONIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSTURE STABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGIDITY; SEIZURE; SEXUAL DYSFUNCTION; SUBTHALAMIC NUCLEUS; TREMOR; CLINICAL TRIAL; DISABILITY; DRUG EFFECT; ELECTRODE; HOSPITALIZATION; LONGITUDINAL STUDY; METHODOLOGY; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TREATMENT OUTCOME;

DEEP BRAIN STIMULATION; DISABILITY EVALUATION; DOPAMINE AGENTS; ELECTRODES, IMPLANTED; FEMALE; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67651151387     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22390     Document Type: Article

References (25)

1. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
2. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
3. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-S304.
4. Liang GS, Chou KL, Baltuch GH, et al. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease. Stereotact Funct Neurosurg 2006; 84:221-227.
5. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008;14:114-119.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
7. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
8. Koss AM, Alterman RL, Tagliati M, Shils JL. Calculating total electrical energy delivered by deep brain stimulation systems. Ann Neurol 2005;58:168.
9. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-1550.
10. Krack P, Batir A, van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
11. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640-1644.
12. Hilker R, Portman AT, Voges J, et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 2005;76:1217-1221.
13. Hariz MI, Johansson F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov Disord 2001;16:166-168.
14. McClelland S, Vonsattel JP, Garcia RE, et al. Relationship of clinical ef.cacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clin Neuropathol 2007;26: 267-275.
15. Benabid AL, Benazzouz A, Limousin P, et al. Dyskinesias and the subthalamic nucleus. Ann Neurol 2000;47(Suppl 1):S189-S192.
16. Bejjani BP, Arnulf I, Demeret S, et al. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible? Ann Neurol 2000;47:655-658.
17. Oueslati A, Sgambato-Faure V, Melon C, et al. High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease. J Neurosci 2007;27:2377-2386.
18. Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact Funct Neurosurg 2006;84:176-179.
19. Herzog J, Pinsker M, Wasner M, et al. Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 2007;22:679-684.
20. Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007;68:267-271.
21. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 1987;37:1539-1542.
22. Clissold BG, McColl CD, Reardon KR, Shiff M, Kempster PA. Longitudinal study of the motor response to levodopa in Parkinson's disease. Mov Disord 2006;21:2116-2121.
23. Breit S, Bouali-Benazzouz R, Benabid AL, Benazzouz A. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur J Neurosci 2001;14:1833-1842.
24. Florio T, Scarnati E, Confalone G, et al. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. Eur J Neurosci 2007;25:1174-1186.
25. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130:1596-1607.